HOURHour Loop Inc
$1.76
$0.00
(0.00%)
Closed $1.76
$0.18
(10.23%)
After Hours
Reported EarningsMar 27
Mkt Cap$61.94M
Vol35,387.00
Fundamentals
Mkt Cap
$61.94M
Volume
-
52W High
$6.84
52W Low
$1.20
PE Ratio
33.02
Avg. Volume
191,296.59
EPS (Annual)
$0.0485
Rev/Employee
$895,850.54
Earnings
Mar 27
46
Neutral Sentiment
How do you feel about HOUR?
HOUR's Q1 Earnings Flat Y/Y on Higher Shipping Costs, Stock Down 13%
Hour Loop's Q1 earnings remain flat year over year despite 16% revenue growth as higher storage and inbound shipping costs pressure margins.
Zacks
Hour Loop, Inc. (NASDAQ:HOUR) Short Interest Up 47.5% in March
Hour Loop, Inc. (NASDAQ:HOUR - Get Free Report) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totaling 21,123 shares, a growth of 47.5...
MarketBeat
HOUR's 2025 Earnings Rise Y/Y Driven by Multi-Channel Expansion
Hour Loop reports a year-over-year increase in 2025 EPS and revenue, supported by efficiency gains and expanding sales channels despite tariff and macroeconomic pressures.
Zacks
Hour Loop, Inc. (NASDAQ:HOUR) Short Interest Down 39.4% in March
Hour Loop, Inc. (NASDAQ:HOUR - Get Free Report) was the target of a large drop in short interest in the month of March. As of March 13th, there was short interest totaling 14,320 shares, a drop of...
MarketBeat
Hour Loop (NASDAQ:HOUR) Shares Up 0.5% - Should You Buy?
Hour Loop (NASDAQ:HOUR) Trading Up 0.5% - Time to Buy...
MarketBeat
Hour Loop, Inc. Announces Advance In Full Year Bottom Line
(RTTNews) - Hour Loop, Inc. (HOUR) revealed a profit for its full year that Increased, from last year...
Nasdaq News: Markets
The Zacks Analyst Blog Highlights Exxon Mobil, Palantir, AstraZeneca, Gencor Industries and Hour Loop
Exxon Mobil, Palantir and AstraZeneca lead Zacks' latest analyst reports, highlighting strong production growth, AI momentum and a robust drug pipeline.
Zacks
Top Analyst Reports for Exxon Mobil, Palantir & AstraZeneca
Exxon Mobil leads fresh analyst reports as Permian and Guyana output power growth, while Palantir's AI platforms and AstraZeneca's drug pipeline highlight key momentum.
Zacks
Hour Loop Rallies 17% in 6 Months: Should You Buy the Stock?
HOUR is poised to gain from expanding e-commerce market, leveraging its scalable wholesale platform and advanced data analytics capabilities to drive consistent sales growth and profitability.
Zacks
Short Interest in Hour Loop, Inc. (NASDAQ:HOUR) Declines By 17.0%
Hour Loop, Inc. (NASDAQ:HOUR - Get Free Report) was the target of a significant decline in short interest in January. As of January 30th, there was short interest totaling 21,490 shares, a decline of...
MarketBeat
<
1
2
...
>